Related references
Note: Only part of the references are listed.The management impact of 68gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (68Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer
Meghana Kulkarni et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics
Kambiz Rahbar et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction
Julian Mueller et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Impact of 68Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management
Asim Afaq et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
The Impact of 68Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study
Paul J. Roach et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer
Michael S. Hofman et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
Frederik L. Giesel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling
Jennifer D. Young et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities
Zora Novakova et al.
FEBS JOURNAL (2016)
The biological inorganic chemistry of zinc ions
Artur Krezel et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)
Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals
Till Wuestemann et al.
THERANOSTICS (2016)
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
Martina Benesova et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Design and preclinical evaluation of a 99mTc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA)
Florian Kampmeier et al.
EJNMMI RESEARCH (2014)
Comparability of Mixed IC50 Data - A Statistical Analysis
Tuomo Kalliokoski et al.
PLOS ONE (2013)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
Glutamate Carboxypeptidase II: An Overview of Structural Studies and Their Importance for Structure-Based Drug Design and Deciphering the Reaction Mechanism of the Enzyme
J. Pavlicek et al.
CURRENT MEDICINAL CHEMISTRY (2012)
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
Ying Chen et al.
CLINICAL CANCER RESEARCH (2011)
A Concise Synthesis of Substituted Thiourea Derivatives in Aqueous Medium
Mahagundappa R. Maddani et al.
JOURNAL OF ORGANIC CHEMISTRY (2010)
Reaction Mechanism of Glutamate Carboxypeptidase II Revealed by Mutagenesis, X-ray Crystallography, and Computational Methods
Vojtech Klusak et al.
BIOCHEMISTRY (2009)
Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III
Klara Hlouchova et al.
FEBS JOURNAL (2009)
Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99mTc-Radioimaging Agents
Sumith A. Kularatne et al.
MOLECULAR PHARMACEUTICS (2009)
Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization
Cyril Barinka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Influence of glycine on the nonlinear optical (NLO) properties of zinc (tris) thiourea sulfate (ZTS) single crystal
N. R. Dhumane et al.
OPTICAL MATERIALS (2008)
Analysis of zinc-ligand bond lengths in metalloproteins: Trends and patterns
Bruno Tamames et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
A high-resolution structure of ligand-free human glutamate carboxypeptidase II
Cyril Barinka et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2007)
NAAG peptidase inhibitors and their potential for diagnosis and therapy
J Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: Efficacy as analgesic agents
AP Kozikowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
A Ghosh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene
DS O'Keefe et al.
PROSTATE (2004)
Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II:: Discovery of an orally active GCP II inhibitor
P Majer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
11C-MCG: Synthesis, Uptake Selectivity, and Primate PET of a Probe for Glutamate Carboxypeptidase II (NAALADase)
Martin G. Pomper et al.
MOLECULAR IMAGING (2002)
Design of NAALADase inhibitors: A novel neuroprotective strategy
PF Jackson et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase)
AP Kozikowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Share Paper
